
Bioorganic and Medicinal Chemistry Letters p. 2745 - 2749 (2010)
Update date:2022-07-29
Topics:
Raeppel, Stéphane
Gaudette, Frédéric
Mannion, Michael
Claridge, Stephen
Saavedra, Oscar
Isakovic, Ljubomir
Déziel, Robert
Beaulieu, Normand
Beaulieu, Carole
Dupont, Isabelle
Nguyen, Hannah
Wang, James
Macleod, A. Robert
Maroun, Christiane
Besterman, Jeffrey M.
Vaisburg, Arkadii
A novel series of N-(3-fluoro-4-(2-substituted-thieno[3,2-b]pyridin-7-yloxy)phenyl)-1-phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxamides targeting RON receptor tyrosine kinase was designed and synthesized. SAR study of the series allowed us to identify compounds possessing either inhibitory activity of RON kinase enzyme in the low nanomolar range with low residual activity against the closely related c-Met or potent dual inhibitory activity against RON and c-Met, - with no significant activity against VEGFR2 in both cases.
Contact:+86-574-89075960
Address:#100 Xiang Yun Road, New High tech area, Ningbo, China
Contact:13357117572
Address:No.149 Shiji dadao Road.
Anhui Eapearl Chemical Co., Ltd.
Contact:86-562-5858458
Address:358 South Huaihe Road
ABA Chemicals (Shanghai) Limited
Contact:021- 5115 9199-232
Address:Suite 18D, #201 Ningxia Road,
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Doi:10.3184/030823410X12627991159610
(2010)Doi:10.1007/BF00598403
(1989)Doi:10.1002/adsc.201000111
(2010)Doi:10.1002/hc.20577
(2010)Doi:10.1016/j.molcatb.2013.03.015
(2013)Doi:10.1016/j.bmc.2010.04.035
(2010)